問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
蘇勇誠
下載
2016-12-29 - 2023-09-28
Condition/Disease
Hormone Receptor-Positive Advanced Breast Cancer
Test Drug
NA
Participate Sites9Sites
Recruiting6Sites
Terminated2Sites
Division of Hematology & Oncology
未分科
2019-04-01 - 2027-04-24
Participate Sites5Sites
Recruiting5Sites
2018-01-01 - 2020-06-30
solid tumor
HLX10
2019-03-01 - 2021-02-28
Metastatic Prostate Cancer
Oradoxel (Docetaxel + HM30181)
Participate Sites3Sites
Recruiting3Sites
全部
